Federal Supply Schedule 36F79726D0190
Award Date 9/1/26
Last Date to Order 8/31/31
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Department of Veterans Affairs issued a Federal Supply Schedule contract to Sumitomo Pharma America, Inc. under Schedule 65 I B (Pharmaceuticals and Drugs) on July 1, 2019, with a ceiling value of $2.532 billion and a completion date of September 1, 2026. The contract has been cancelled. No set-aside category applied to this award. Sumitomo Pharma America, Inc. supplied pharmaceutical and hematology-related products under this multiple-award schedule vehicle, through which the VA and other...
- The Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a Federal Supply Schedule contract to Endo Usa, Inc. under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on September 29, 2020, with a ceiling value of $1,873,742,173.50 and performance extending through September 30, 2027. The schedule covers drugs, pharmaceuticals, and hematology-related products available for ordering by federal agencies across the VA system. This is a multiple-award vehicle, enabling...
- The Department of Veterans Affairs issued a Federal Supply Schedule contract to Amphastar Pharmaceuticals, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on January 15, 2022, with a ceiling value of $58.244 million and an ultimate completion date of January 14, 2027. The contract covers drugs, pharmaceuticals, and hematology-related products under Special Item Number 65 I B. No set-aside category applies. Place of performance is nationwide under this multi-agency schedule vehicle....
- The Department of Veterans Affairs Veterans Health Administration awarded a Federal Supply Schedule contract to Mylan Specialty LP on January 15, 2022, under the Pharmaceuticals and Drugs schedule (FSS-61-IB), a multi-agency vehicle enabling streamlined ordering of drugs, pharmaceuticals, and hematology-related products with a contract ceiling of $514,849,130. The schedule contract runs through January 14, 2027. As a catalog-based Federal Supply Schedule, agencies place orders against Mylan...
- The Department of Veterans Affairs, Veterans Integrated Service Network 12, issued a Federal Supply Schedule contract to Astellas Pharma US, Inc. for drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B on September 30, 2021, with a contract ceiling of $3.5 billion and an ultimate completion date of September 29, 2026. The contractor operates under the Pharmaceuticals and Drugs schedule (FSS-61-IB) with no set-aside designation. Place of performance spans Veterans Health...
- The Department of Veterans Affairs issued a Federal Supply Schedule contract to Royal Pharmaceuticals LLC under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, effective October 1, 2019, with a contract ceiling of $750,000. The contract covers drugs, pharmaceuticals, and hematology-related products available through the VA's multiple-award Federal Supply Schedule vehicle. Performance extends through April 30, 2027, following a temporary contract extension from October 1, 2026 through that...
- The U.S. Department of Veterans Affairs issued a Federal Supply Schedule contract to Aveo Pharmaceuticals, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on October 15, 2021, with a contract ceiling of $48,653,265. The contract covers Special Item Number 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, and is structured as a multiple-award schedule vehicle. No set-aside category applies. The Veterans Integrated Service Network 12 is the funding federal agency....
- The Department of Veterans Affairs issued a Federal Supply Schedule contract to Scilex Pharmaceuticals Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on March 1, 2019, with a contract ceiling of $300,000.00 and ultimate completion date of August 1, 2027. The contract covers Special Item Number 65 I B, drugs, pharmaceuticals, and hematology-related products, and represents a contract extension under the multiple-award schedule vehicle. The Department of Veterans Affairs, Veterans...
- The Department of Veterans Affairs issued a Federal Supply Schedule contract to Sun Pharmaceutical Industries, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on July 15, 2021, with a ceiling value of $117,409,110.00 and a period of performance extending through July 14, 2027. The contract covers Special Item Number 65 I B, encompassing drugs, pharmaceuticals, and hematology-related products. This is a multiple-award schedule vehicle, enabling agencies to place orders against the...
- The Department of Veterans Affairs issued a Federal Supply Schedule contract to WG Critical Care, LLC under Schedule 65 I B (Pharmaceuticals and Drugs) on June 15, 2024. The contract covers drugs, pharmaceuticals, and hematology-related products available for ordering by VA and other federal agencies through GSA's catalog-based ordering process. The contract ceiling is $16,124,000 and runs through June 14, 2029. This is a multiple-award schedule, meaning other contractors also hold concurrent...